CVR 37315788Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)GaltenFounded 15 Dec 2015
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Eurofins Genomics Denmark A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
4
CVR, 2025
Gross profit
9.9M
DKK, annual report 2023
-40.5% on 2022
Result
+2.6M
DKK, annual report 2023
Equity
8.7M
DKK, annual report 2023
EUROFINS GENOMICS HOLDING DENMARK A/SCVR 35039503, 100% of capital and votes, until 1 May 2025
Jacob Sickmann Ransborguntil 1 May 2025
No current owner is registered.
CVR 35039503100% of capital and votes15 Dec 2015 to 1 May 2025
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Apr 2025, monthly: 4 employees, 4 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 6 | 7 | 7 | 8 | 8 | 7 | 8 | 8 | 7 | 7 | 7 | 8 | 6 | 7 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | 4 | 4 | 4 |
| FTE | 6 | 7 | 7 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 9 | 3 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 6 | 4 | 4 | 4 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Apr 2025, published 20 Jun 2025.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2023, DKK: Gross profit 9.9M, Operating profit 3.1M, Result for the year 2.6M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2023, DKK: Total assets 44.9M, Equity 8.7M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Gross profit | 7,306 | 10,166 | 20,862 | 16,575 | 9,856 |
| Operating profit | +258 | +4,275 | +13,844 | +10,137 | +3,060 |
| Result for the year | -30 | +3,244 | +10,599 | +7,550 | +2,626 |
| Equity | 2,213 | 5,457 | 16,056 | 13,606 | 8,732 |
| Total assets | 30,416 | 38,883 | 59,083 | 48,465 | 44,941 |
| Employees (average) | 6 | 6 | 6 | 7 | 6 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -1.1% | 61.6% | 105.2% | -24.1% | -40.5% |
| EBITDA | 1,609 | 5,630 | 15,213 | 11,525 | 4,402 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | 0% | 0% | 0% | 16.7% | -14.3% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 0note 1 | 69note 1 | 13note 1 | 0note 2 | 0note 1 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Eurofins Genomics Denmark A/S:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 500,000 | None | 500,000 | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
14 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 01.05.2025 opløst ved fusion med CVR-nummer: 10048818 Eurofins Genomics Europe AgriGenomics Products & Services A/S.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 10048818 Eurofins Genomics Europe AgriGenomics Products & Services A/S (fortsættende), der tillige driver virksomhed under navnene AROS Applied Biotechnology A/S, Eurofins Genomics Europe Genotyping A/S, CVR-nummer: 37315788 Eurofins Genomics Denmark A/S (ophørende), der tillige driver virksomhed under navnene Eurofins Genomics A/S og CVR-nummer: 35039503 EUROFINS GENOMICS HOLDING DENMARK A/S (ophørende), der tillige driver virksomhed under navnene Eurofins Safer At Work Nordics A/S, GENOSKAN A/S, Eurofins GenoSkan A/S, Eurofins Safer At Work Denmark A/S.
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 10048818 Eurofins Genomics Europe AgriGenomics Products & Services A/S, CVR-nummer: 37315788 Eurofins Genomics Denmark A/S og CVR-nummer: 35039503 EUROFINS GENOMICS HOLDING DENMARK A/S må antages at være tilstrækkeligt sikrede efter fusionen.
Bestyrelse:
Fratrådte:
Sonja Maria Wiedemann, den 29.02.2024.
Tiltrådte:
Ulrich August Werner Kühle, den 01.03.2024.
Bestyrelse:
Fratrådte:
Stefánia Pcolová, den 27.05.2021.
Tiltrådte:
Jacob Sickmann Ransborg, den 27.05.2021.
Bestyrelse:
Fratrådte:
Bruno Francis Claude Poddevin, den 17.07.2020.
Tiltrådte:
Michael Hadem, den 17.07.2020.
Revision:
Fratrådte:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 15.05.2019.
Tiltrådte:
CVR-NR. 33963556 DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Værkmestergade 2, 18., 8000 Aarhus C, den 15.05.2019.
Direktion:
Fratrådte:
Daniel Schougaard Langhoff, (adm. dir), den 16.05.2019.
Tiltrådte:
Jacob Sickmann Ransborg, (adm. dir), den 16.05.2019.
Vedtægter ændret: 03.01.2019
Nyt navn: Eurofins Genomics Denmark A/S
Nyt binavn: Eurofins Genomics A/S
Bestyrelse:
Fratrådte:
Morten Melbye, den 31.12.2016.
Direktion:
Fratrådte:
Morten Melbye, den 31.12.2016.
Tiltrådte:
Daniel Schougaard Langhoff (adm. dir), den 01.01.2017.
Vedtægter ændret: 30.05.2016
Bestyrelse:
Tiltrådte:
Morten Melbye, den 30.05.2016.
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden i forening med direktøren eller et bestyrelsesmedlem..
Stiftelsesdato: 15.12.2015.
Virkningsdato: 15.12.2015.
Seneste vedtægtsdato: 15.12.2015.
Kapital:
kr. 500.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 500.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 35039503 EUROFINS GENOMICS HOLDING DENMARK A/S, Smedeskovvej 38, 8464 Galten, den 15.12.2015.
Bestyrelse:
Svend Aage Linde (formand), den 15.12.2015, Bruno Francis Claude Poddevin, den 15.12.2015, Thomas Gjelsnes, den 15.12.2015.
Direktion:
Morten Melbye, den 15.12.2015.
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Revision:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Jens Chr.Skous Vej 1, 8000 Aarhus C, den 15.12.2015.
Første regnskabsår:
15.12.2015 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er kontraktforsk-ning, laboratoriemæssig service og handel med knowhow af laboratorieydelser
P-number 1031229290Smedeskovvej 55, 8464 Galten
P-number 1020996842Smedeskovvej 38, 8464 Galten